KD Logo

Leerink Partners initates Climb Bio Inc (CLYM) stock to an Outperform

Climb Bio Inc’s recent filing unveils that its CHIEF ACCOUNTING OFFICER Pimblett Emily unloaded Company’s shares for reported $2495.0 on Dec 19 ’24. In the deal valued at $2.02 per share,1,235 shares were sold. As a result of this transaction, Pimblett Emily now holds 11,329 shares worth roughly $22091.55.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Pimblett Emily sold 1,191 shares, generating $9,741 in total proceeds. Upon selling the shares at $8.18, the CHIEF ACCOUNTING OFFICER now owns 7,564 shares.

Before that, Morisset Valerie sold 69,005 shares. Climb Bio Inc shares valued at $554,170 were divested by the EVP, R&D AND CSO at a price of $8.03 per share. As a result of the transaction, Morisset Valerie now holds 31,317 shares, worth roughly $61068.15.

Leerink Partners initiated its Climb Bio Inc [CLYM] rating to an Outperform in a research note published on December 02, 2024; the price target was $10.

Price Performance Review of CLYM

On Friday, Climb Bio Inc [NASDAQ:CLYM] saw its stock unchanged to $1.95. Over the last five days, the stock has lost -25.00%. Climb Bio Inc shares have fallen nearly -27.78% since the year began. Nevertheless, the stocks have fallen -28.57% over the past one year. While a 52-week high of $11.55 was reached on 05/03/24, a 52-week low of $1.89 was recorded on 12/20/24. SMA at 50 days reached $3.5665, while 200 days put it at $5.6645.

Levels Of Support And Resistance For CLYM Stock

The 24-hour chart illustrates a support level at 1.8517, which if violated will result in even more drops to 1.7533. On the upside, there is a resistance level at 2.0567. A further resistance level may holdings at 2.1633. The Relative Strength Index (RSI) on the 14-day chart is 21.39, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.7132, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.62%. Stochastics %K at 3.81% indicates the stock is a buying.

How much short interest is there in Climb Bio Inc?

A steep rise in short interest was recorded in Climb Bio Inc stocks on 2024-11-29, dropping by 82972.0 shares to a total of 4.9 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 4.98 million shares. There was a decline of -1.69%, which implies that there is a negative sentiment for the stock.

Most Popular